Cargando…
General practitioner attitudes towards prescribing aspirin to carriers of Lynch Syndrome: findings from a national survey
A dose non-inferiority study comparing 100 mg, 300 mg and 600 mg of aspirin for cancer prevention among Lynch Syndrome carriers is underway (Colorectal Adenoma/Carcinoma Prevention Programme trial 3, CaPP3). To guide implementation of the findings, we investigated general practitioner (GP) attitudes...
Autores principales: | Smith, Samuel G., Foy, Robbie, McGowan, Jennifer, Kobayashi, Lindsay C., Burn, John, Brown, Karen, Side, Lucy, Cuzick, Jack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603645/ https://www.ncbi.nlm.nih.gov/pubmed/28434157 http://dx.doi.org/10.1007/s10689-017-9986-9 |
Ejemplares similares
-
Prescribing tamoxifen in primary care for the prevention of breast cancer: a national online survey of GPs’ attitudes
por: Smith, Samuel G, et al.
Publicado: (2017) -
GPs’ willingness to prescribe aspirin for cancer preventive therapy in Lynch syndrome: a factorial randomised trial investigating factors influencing decisions
por: Lloyd, Kelly E, et al.
Publicado: (2023) -
Barriers and facilitators to using aspirin for preventive therapy: a qualitative study exploring the views and experiences of people with Lynch syndrome and healthcare providers
por: Lloyd, Kelly E., et al.
Publicado: (2022) -
The Risk‐Reducing Effect of Aspirin in Lynch Syndrome Carriers: Development and Evaluation of an Educational Leaflet
por: Kaur, Rajneesh, et al.
Publicado: (2022) -
Effects of Aspirin on Colorectal Cancer Related to Lynch Syndrome
por: Beck,, Sarah Leilani
Publicado: (2012)